Lipodystrophy and lipoatrophy

Sculptra, at last!

Graham Stocks — Wed, 25 May 2011 22:46:17 -0700

The sponsor company of Sculptra in Australia, Sanofi- Aventis, has finally had confirmation from Medicare that the two item numbers for the injecting procedure have been approved.

The company will be sending advice to relevant doctors shortly, but the expectation is that the listing will be from 1 July.

The buzz from Boston

Graham Stocks — Wed, 25 May 2011 21:31:59 -0700

The Conference on Retroviruses and Opportunistic Infections reports important advances in HIV treatments and clinicalPertaining to or founded on observation and treatment of participants, as distinguished from theoretical or basic science. care. The 18th CROI was held in Boston in March. Neil McKellar-Stewart highlights some of the good bits.

Sculptra: an update

Graham Stocks — Wed, 02 Mar 2011 21:36:46 -0800

Following the successful listing of Sculptra (poly-L-lactic acid) on the PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. in 2009, many people eligible for the treatment have been eagerly awaiting the listing of an item number to help cover the costs of the procedure.

While the recommendation to list the procedure was made in February last year, there is still no progress on finalising this on the Medicare Benefits Schedule.

FDA approves Egrifta

Graham Stocks — Wed, 01 Dec 2010 17:32:12 -0800

On November 10, the US Food and Drug AdministrationThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA). approved Egrifta (tesamorelin) to treat HIV people with visceral body fat caused through lipodystrophy.

Egrifta is a synthetic growth hormone releasing factor drug that is administered in a once-daily injection.

Rosiglitazone a cardiovascular risk

Graham Stocks — Wed, 01 Dec 2010 17:07:25 -0800

The FDAThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA). has notified healthcare professionals and patients that it will significantly restrict the use of the diabetes[Diabetes mellitus] A disorder in which sugars in the diet cannot be metabolised into energy due to a lack of the enzyme insulin. Late-onset diabetes mellitus may be a long-term side effect of some anti-HIV drugs. drug Avandia (rosiglitazone) to patients with Type 2 diabetes who cannot control their diabetes on other medications.

Ways and means to lower lipids

Graham Stocks — Wed, 08 Sep 2010 20:49:03 -0700

The US Food and Drug Administration (FDAThe U.S. Department of Health and Human Services agency responsible for ensuring the safety and effectiveness of all drugs, biologics, vaccines, and medical devices, including those used in the diagnosis, treatment, and prevention of HIV infection, AIDS, and AIDS-related opportunistic infections. The FDA also works with the blood banking industry to safeguard the nation's blood supply. The Australian equivalent is the Therapeutic Goods Administration (TGA).) recently issued a warning to people taking the highest approved dose of simvastatin, a common cholesterolAn essential component of cell membranes and nerve fibre insulation, cholesterol is important for the metabolism and transport of fatty acids and the production of hormones and Vitamin D. Cholesterol is manufactured by the liver, and is also present in certain foods. High blood cholesterol levels have been linked to heart disease and may be a side effect of some anti-HIV medications.-lowering medication, that they have an increased risk of muscle injury compared to people taking lower doses of the drug.

Egrifta reduces lipo belly fat

Graham Stocks — Wed, 01 Sep 2010 23:23:05 -0700

There is currently no effective drug treatment available for the treatmen of excess abdominal fat caused by lipodystrophy – but that could change very soon.

Body Shape Changes

Graham Stocks — Wed, 07 Apr 2010 21:35:02 -0700

Historically, HIV disease has been associated with changes to body shape.

The cheek of some people

Graham Stocks — Wed, 25 Nov 2009 21:18:08 -0800

The Commonwealth’s recent decision to list Sculptra on the PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. is exciting news for Australia’s positive community. Anyone with HIV treatmentassociated facial lipoatrophy is now subsidised to receive up to eight vials for their first treatment followed by topups of two vials every two years

New treatment for HIV-associated facial wasting

Paul Kidd — Mon, 31 Aug 2009 07:00:01 -0700

Today’s PBS[Pharmaceutical Benefits Scheme] The federal government program which subsidises medication costs in Australia. Anti-HIV drugs are part of a special part of the PBS called Section 100 (S100) which is used for expensive, highly specialised drugs. listing of a treatment for HIV-associated facial wasting will provide substantial improvements in quality of life for people living with HIV, the National Association of People Living with HIV/AIDS (NAPWA) has said.